233 related articles for article (PubMed ID: 31436048)
1. Autocrine activin A signalling in ovarian cancer cells regulates secretion of interleukin 6, autophagy, and cachexia.
Pettersen K; Andersen S; van der Veen A; Nonstad U; Hatakeyama S; Lambert C; Lach-Trifilieff E; Moestue S; Kim J; Grønberg BH; Schilb A; Jacobi C; Bjørkøy G
J Cachexia Sarcopenia Muscle; 2020 Feb; 11(1):195-207. PubMed ID: 31436048
[TBL] [Abstract][Full Text] [Related]
2. The systemic activin response to pancreatic cancer: implications for effective cancer cachexia therapy.
Zhong X; Pons M; Poirier C; Jiang Y; Liu J; Sandusky GE; Shahda S; Nakeeb A; Schmidt CM; House MG; Ceppa EP; Zyromski NJ; Liu Y; Jiang G; Couch ME; Koniaris LG; Zimmers TA
J Cachexia Sarcopenia Muscle; 2019 Oct; 10(5):1083-1101. PubMed ID: 31286691
[TBL] [Abstract][Full Text] [Related]
3. Activin-β(c) reduces reproductive tumour progression and abolishes cancer-associated cachexia in inhibin-deficient mice.
Gold E; Marino FE; Harrison C; Makanji Y; Risbridger G
J Pathol; 2013 Mar; 229(4):599-607. PubMed ID: 23180294
[TBL] [Abstract][Full Text] [Related]
4. Elevated expression of activins promotes muscle wasting and cachexia.
Chen JL; Walton KL; Winbanks CE; Murphy KT; Thomson RE; Makanji Y; Qian H; Lynch GS; Harrison CA; Gregorevic P
FASEB J; 2014 Apr; 28(4):1711-23. PubMed ID: 24378873
[TBL] [Abstract][Full Text] [Related]
5. Growth of ovarian cancer xenografts causes loss of muscle and bone mass: a new model for the study of cancer cachexia.
Pin F; Barreto R; Kitase Y; Mitra S; Erne CE; Novinger LJ; Zimmers TA; Couch ME; Bonewald LF; Bonetto A
J Cachexia Sarcopenia Muscle; 2018 Aug; 9(4):685-700. PubMed ID: 30009406
[TBL] [Abstract][Full Text] [Related]
6. Cancer cachexia associates with a systemic autophagy-inducing activity mimicked by cancer cell-derived IL-6 trans-signaling.
Pettersen K; Andersen S; Degen S; Tadini V; Grosjean J; Hatakeyama S; Tesfahun AN; Moestue S; Kim J; Nonstad U; Romundstad PR; Skorpen F; Sørhaug S; Amundsen T; Grønberg BH; Strasser F; Stephens N; Hoem D; Molven A; Kaasa S; Fearon K; Jacobi C; Bjørkøy G
Sci Rep; 2017 May; 7(1):2046. PubMed ID: 28515477
[TBL] [Abstract][Full Text] [Related]
7. Development of ovarian tumour causes significant loss of muscle and adipose tissue: a novel mouse model for cancer cachexia study.
Luan Y; Zhang Y; Yu SY; You M; Xu PC; Chung S; Kurita T; Zhu J; Kim SY
J Cachexia Sarcopenia Muscle; 2022 Apr; 13(2):1289-1301. PubMed ID: 35044098
[TBL] [Abstract][Full Text] [Related]
8. Differential Effects of IL6 and Activin A in the Development of Cancer-Associated Cachexia.
Chen JL; Walton KL; Qian H; Colgan TD; Hagg A; Watt MJ; Harrison CA; Gregorevic P
Cancer Res; 2016 Sep; 76(18):5372-82. PubMed ID: 27328730
[TBL] [Abstract][Full Text] [Related]
9. Interleukin-6 initiates muscle- and adipose tissue wasting in a novel C57BL/6 model of cancer-associated cachexia.
Pototschnig I; Feiler U; Diwoky C; Vesely PW; Rauchenwald T; Paar M; Bakiri L; Pajed L; Hofer P; Kashofer K; Sukhbaatar N; Schoiswohl G; Weichhart T; Hoefler G; Bock C; Pichler M; Wagner EF; Zechner R; Schweiger M
J Cachexia Sarcopenia Muscle; 2023 Feb; 14(1):93-107. PubMed ID: 36351437
[TBL] [Abstract][Full Text] [Related]
10. Muscle NAD
Hulmi JJ; Penna F; Pöllänen N; Nissinen TA; Hentilä J; Euro L; Lautaoja JH; Ballarò R; Soliymani R; Baumann M; Ritvos O; Pirinen E; Lalowski M
Mol Metab; 2020 Nov; 41():101046. PubMed ID: 32599075
[TBL] [Abstract][Full Text] [Related]
11. Blockade of the IL-6 trans-signalling/STAT3 axis suppresses cachexia in Kras-induced lung adenocarcinoma.
Miller A; McLeod L; Alhayyani S; Szczepny A; Watkins DN; Chen W; Enriori P; Ferlin W; Ruwanpura S; Jenkins BJ
Oncogene; 2017 May; 36(21):3059-3066. PubMed ID: 27893707
[TBL] [Abstract][Full Text] [Related]
12. Development of a traditional Chinese medicine-based agent for the treatment of cancer cachexia.
Wu KC; Chu PC; Cheng YJ; Li CI; Tian J; Wu HY; Wu SH; Lai YC; Kao HH; Hsu AL; Lin HW; Lin CH
J Cachexia Sarcopenia Muscle; 2022 Aug; 13(4):2073-2087. PubMed ID: 35718751
[TBL] [Abstract][Full Text] [Related]
13. Activin signal promotes cancer progression and is involved in cachexia in a subset of pancreatic cancer.
Togashi Y; Kogita A; Sakamoto H; Hayashi H; Terashima M; de Velasco MA; Sakai K; Fujita Y; Tomida S; Kitano M; Okuno K; Kudo M; Nishio K
Cancer Lett; 2015 Jan; 356(2 Pt B):819-27. PubMed ID: 25449777
[TBL] [Abstract][Full Text] [Related]
14. Modelling three-dimensional cancer-associated cachexia and therapy: The molecular basis and therapeutic potential of interleukin-6 transignalling blockade.
Cosentino M; Forcina L; Zouhair M; Apa L; Genovese D; Boccia C; Rizzuto E; Musarò A
J Cachexia Sarcopenia Muscle; 2023 Dec; 14(6):2550-2568. PubMed ID: 37727078
[TBL] [Abstract][Full Text] [Related]
15. Activin A-Expressing Polymorphonuclear Myeloid-Derived Suppressor Cells Infiltrate Skeletal and Cardiac Muscle and Promote Cancer Cachexia.
Dzierlega K; Chakraborty M; Lee M; Soliman AM; Parker D; Khan S; Chan YT; Akbari M; Yokota T; Winer S; Baker K; Tsai S; Winer DA; Clemente-Casares X
J Immunol; 2023 Aug; 211(3):497-507. PubMed ID: 37294291
[TBL] [Abstract][Full Text] [Related]
16. Treating cachexia using soluble ACVR2B improves survival, alters mTOR localization, and attenuates liver and spleen responses.
Nissinen TA; Hentilä J; Penna F; Lampinen A; Lautaoja JH; Fachada V; Holopainen T; Ritvos O; Kivelä R; Hulmi JJ
J Cachexia Sarcopenia Muscle; 2018 Jun; 9(3):514-529. PubMed ID: 29722201
[TBL] [Abstract][Full Text] [Related]
17. Activin regulates estrogen receptor gene expression in the mouse ovary.
Kipp JL; Kilen SM; Woodruff TK; Mayo KE
J Biol Chem; 2007 Dec; 282(50):36755-65. PubMed ID: 17951260
[TBL] [Abstract][Full Text] [Related]
18. Atractylenolide I ameliorates cancer cachexia through inhibiting biogenesis of IL-6 and tumour-derived extracellular vesicles.
Fan M; Gu X; Zhang W; Shen Q; Zhang R; Fang Q; Wang Y; Guo X; Zhang X; Liu X
J Cachexia Sarcopenia Muscle; 2022 Dec; 13(6):2724-2739. PubMed ID: 36085573
[TBL] [Abstract][Full Text] [Related]
19. Generation of reporter cell lines for factors inducing muscle wasting in cancer cachexia.
Cao Z; Jose I; Glab J; Puthalakath H; Osellame LD; Hoogenraad NJ
Anal Biochem; 2020 Oct; 606():113877. PubMed ID: 32738212
[TBL] [Abstract][Full Text] [Related]
20. Generation and initial characterization of novel tumour organoid models to study human pancreatic cancer-induced cachexia.
Vaes RDW; van Dijk DPJ; Welbers TTJ; Blok MJ; Aberle MR; Heij L; Boj SF; Olde Damink SWM; Rensen SS
J Cachexia Sarcopenia Muscle; 2020 Dec; 11(6):1509-1524. PubMed ID: 33047901
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
